Unipharm Limited
06902216
Healthy
- Current liabilities exceed current assets (-10)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 11/05/2009
PHARMACIST
BRITISH · UNITED KINGDOM · Age 52
Also on 8 other boards
director · Since 30/04/2013
COMPANY DIRECTOR
BRITISH · ENGLAND · Age 46
Also on 2 other boards
director · Since 20/03/2024
DIRECTOR
BRITISH · ENGLAND · Age 24
Also on 2 other boards
Persons with Significant Control
Mr Sayedur Rahman
British · England · Age 46
290, Brixton Road, London, SW9 6AG
Notified 06/04/2016
Mr Ataur Rahman
British · United Kingdom · Age 52
290, Brixton Road, London, SW9 6AG
Notified 06/04/2016
Mr Rahman Mujibun
British · England · Age 45
290, Brixton Road, London, SW9 6AG
Notified 06/04/2016
CompanyRankvs 565+ SIC 46460 peers72
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/05/2025
Net Worth
£479k
Balance sheet strength
Cash
£115k
Cash in the bank
Net Current Assets
-£43k
Working capital
Current Assets
£518k
Current Liabilities
£562k
Fixed Assets
£1.0M
Debtors
£262k
Profit After Tax
-£140k
Tax at Year End(2024)
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 0.92 | +£0 |
| 2025 | 0.92 | — |
| 2024 | 3.74 | — |
| 2023 | 3.81 | — |
| 2022 | 3.61 | — |
| 2021 | 2.92 | — |
| 2020 | 2.41 | — |
| 2019 | 2.30 | — |
| 2018 | 2.43 | — |
Derived from filed accounts. Not audited figures.